Role of anti-Mullerian hormone in polycystic ovary syndrome

Abstract Polycystic ovary syndrome (PCOS) is the most common gynecological endocrine disorders affecting up to 10% of all females in their reproductive age, and its cause onset still elusive. A spectrum recent research reflected diverse associations between increased plasma level anti-Mullerian hormone (AMH) different clinical features PCOS. Since AMH levels reflect pool growing follicles that potentially can ovulate, it be stated serum used assess “functional ovarian reserve,” rather mentioning as “ovarian reserve.” also appears a premier parameter for assessment atrophied follicular response age individuals. hinders development well recruitment ultimately resulting arrest which key pathophysiologic condition Furthermore, FSH-induced aromatase activity remains inhibited by aids emergence other associated signs PCOS, such excess androgen, followed insulin resistance among PCOS Given versatile association with scarcity literature explaining underling mechanisms how relates this review article will discuss roles pathogenesis may introduce new era treatment approach